Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Sex-specific norms for verbal memory tests may improve diagnostic accuracy of amnestic MCI.

Sundermann EE, Maki P, Biegon A, Lipton RB, Mielke MM, Machulda M, Bondi MW; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2019 Oct 9. pii: 10.1212/WNL.0000000000008467. doi: 10.1212/WNL.0000000000008467. [Epub ahead of print]

PMID:
31597708
2.

Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial.

Weiser M, Levi L, Zamora D, Biegon A, SanGiovanni JP, Davidson M, Burshtein S, Gonen I, Radu P, Slobozean Pavalache K, Nastas I, Hemi R, Ryan T, Davis JM.

JAMA Psychiatry. 2019 Jul 31. doi: 10.1001/jamapsychiatry.2019.1842. [Epub ahead of print]

PMID:
31365044
3.

Stimulation of N-methyl-D-aspartate receptors by exogenous and endogenous ligands improves outcome of brain injury.

Biegon A, Liraz-Zaltsman S, Shohami E.

Curr Opin Neurol. 2018 Dec;31(6):687-692. doi: 10.1097/WCO.0000000000000612. Review.

PMID:
30382950
4.

Nuclear Medicine Procedures Do Not Pose Cancer Risks in Women-Unappreciated or Otherwise.

Biegon A, Franceschi D, Schweitzer M.

J Nucl Med. 2018 Oct;59(10):1491. doi: 10.2967/jnumed.118.218834. Epub 2018 Sep 13. No abstract available.

5.

Nuclear Medicine Procedures in Women: Unappreciated Risks to Reproductive Organs?

Biegon A, Franceschi D, Schweitzer ME.

Radiology. 2018 Oct;289(1):25-27. doi: 10.1148/radiol.2018172344. Epub 2018 Jul 10. Review. No abstract available.

PMID:
29989525
6.

Enhancement of Brain d-Serine Mediates Recovery of Cognitive Function after Traumatic Brain Injury.

Liraz-Zaltsman S, Slusher B, Atrakchi-Baranes D, Rosenblatt K, Friedman Levi Y, Kesner E, Silva AJ, Biegon A, Shohami E.

J Neurotrauma. 2018 Jul 15;35(14):1667-1680. doi: 10.1089/neu.2017.5561. Epub 2018 Apr 30.

PMID:
29648983
7.

Aromatase and neuroinflammation in rat focal brain ischemia.

Zhong YH, Dhawan J, Kovoor JA, Sullivan J, Zhang WX, Choi D, Biegon A.

J Steroid Biochem Mol Biol. 2017 Nov;174:225-233. doi: 10.1016/j.jsbmb.2017.09.019. Epub 2017 Sep 28.

PMID:
28964927
8.

Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer's Disease Pathology in Women versus Men?

Sundermann EE, Biegon A, Rubin LH, Lipton RB, Landau S, Maki PM; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;56(3):947-957. doi: 10.3233/JAD-160716.

PMID:
28106548
9.

Female advantage in verbal memory: Evidence of sex-specific cognitive reserve.

Sundermann EE, Maki PM, Rubin LH, Lipton RB, Landau S, Biegon A; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 Nov 1;87(18):1916-1924. Epub 2016 Oct 5.

10.

Cognitive Deficits Post-Traumatic Brain Injury and Their Association with Injury Severity and Gray Matter Volumes.

Livny A, Biegon A, Kushnir T, Harnof S, Hoffmann C, Fruchter E, Weiser M.

J Neurotrauma. 2017 Apr 1;34(7):1466-1472. doi: 10.1089/neu.2016.4598. Epub 2016 Dec 2.

PMID:
27750571
11.

Automated Video Analysis of Non-verbal Communication in a Medical Setting.

Hart Y, Czerniak E, Karnieli-Miller O, Mayo AE, Ziv A, Biegon A, Citron A, Alon U.

Front Psychol. 2016 Aug 23;7:1130. doi: 10.3389/fpsyg.2016.01130. eCollection 2016.

12.

Manipulating the Placebo Response in Experimental Pain by Altering Doctor's Performance Style.

Czerniak E, Biegon A, Ziv A, Karnieli-Miller O, Weiser M, Alon U, Citron A.

Front Psychol. 2016 Jun 30;7:874. doi: 10.3389/fpsyg.2016.00874. eCollection 2016.

13.

Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine.

Liraz-Zaltsman S, Yaka R, Shabashov D, Shohami E, Biegon A.

J Mol Neurosci. 2016 Sep;60(1):46-62. doi: 10.1007/s12031-016-0786-8. Epub 2016 Jul 16.

PMID:
27421842
14.

Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy.

Sundermann EE, Biegon A, Rubin LH, Lipton RB, Mowrey W, Landau S, Maki PM; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 Apr 12;86(15):1368-1376. doi: 10.1212/WNL.0000000000002570. Epub 2016 Mar 16.

15.

In vivo visualization of aromatase in animals and humans.

Biegon A.

Front Neuroendocrinol. 2016 Jan;40:42-51. doi: 10.1016/j.yfrne.2015.10.001. Epub 2015 Oct 9. Review.

16.

Region-specific changes in brain diffusivity in fetal isolated mild ventriculomegaly.

Yaniv G, Katorza E, Bercovitz R, Bergman D, Greenberg G, Biegon A, Hoffmann C.

Eur Radiol. 2016 Mar;26(3):840-8. doi: 10.1007/s00330-015-3893-y. Epub 2015 Jul 2.

PMID:
26135001
17.

Aromatase imaging with [N-methyl-11C]vorozole PET in healthy men and women.

Biegon A, Alexoff DL, Kim SW, Logan J, Pareto D, Schlyer D, Wang GJ, Fowler JS.

J Nucl Med. 2015 Apr;56(4):580-5. doi: 10.2967/jnumed.114.150383. Epub 2015 Feb 19.

18.

Region-specific reductions in brain apparent diffusion coefficient in cytomegalovirus-infected fetuses.

Yaniv G, Hoffmann C, Weisz B, Lipitz S, Katorza E, Kidron D, Bergman D, Biegon A.

Ultrasound Obstet Gynecol. 2016 May;47(5):600-7. doi: 10.1002/uog.14737.

19.

Quantitative magnetic resonance imaging of the fetal brain in utero: Methods and applications.

Biegon A, Hoffmann C.

World J Radiol. 2014 Aug 28;6(8):523-9. doi: 10.4329/wjr.v6.i8.523. Review.

20.

Kinetic analysis of [11C]vorozole binding in the human brain with positron emission tomography.

Logan J, Kim SW, Pareto D, Telang F, Wang GJ, Fowler JS, Biegon A.

Mol Imaging. 2014;13:1-12.

PMID:
24824855
21.

Regional apparent diffusion coefficient values in 3rd trimester fetal brain.

Hoffmann C, Weisz B, Lipitz S, Yaniv G, Katorza E, Bergman D, Biegon A.

Neuroradiology. 2014 Jul;56(7):561-7. doi: 10.1007/s00234-014-1359-6. Epub 2014 Apr 20.

PMID:
24748534
22.

Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease.

Gaisler-Salomon I, Kravitz E, Feiler Y, Safran M, Biegon A, Amariglio N, Rechavi G.

Neurobiol Aging. 2014 Aug;35(8):1785-91. doi: 10.1016/j.neurobiolaging.2014.02.018. Epub 2014 Mar 1.

PMID:
24679603
23.

In vivo imaging of brain aromatase in female baboons: [11C]vorozole kinetics and effect of the menstrual cycle.

Pareto D, Biegon A, Alexoff D, Carter P, Shea C, Muench L, Xu Y, Fowler JS, Kim SW, Logan J.

Mol Imaging. 2013 Nov-Dec;12(8). doi: 10.2310/7290.2013.00068.

PMID:
24447618
24.

Hippocampal glutamate NMDA receptor loss tracks progression in Alzheimer's disease: quantitative autoradiography in postmortem human brain.

Kravitz E, Gaisler-Salomon I, Biegon A.

PLoS One. 2013 Nov 28;8(11):e81244. doi: 10.1371/journal.pone.0081244. eCollection 2013.

25.

Novel approach to the role of NMDA receptors in traumatic brain injury.

Shohami E, Biegon A.

CNS Neurol Disord Drug Targets. 2014;13(4):567-73. Review.

PMID:
24168367
26.

Persistent region-dependent neuroinflammation, NMDA receptor loss and atrophy in an animal model of penetrating brain injury.

Grossman R, Paden CM, Fry PA, Rhodes RS, Biegon A.

Future Neurol. 2012 May 1;7(3):329-339.

27.

Potential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brain.

Biegon A, Alia-Klein N, Fowler JS.

Front Pharmacol. 2012 Nov 6;3:185. doi: 10.3389/fphar.2012.00185. eCollection 2012.

28.

A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke.

Dhawan J, Benveniste H, Luo Z, Nawrocky M, Smith SD, Biegon A.

Future Neurol. 2011 Nov 1;6(6):823-834.

29.

Gene x disease interaction on orbitofrontal gray matter in cocaine addiction.

Alia-Klein N, Parvaz MA, Woicik PA, Konova AB, Maloney T, Shumay E, Wang R, Telang F, Biegon A, Wang GJ, Fowler JS, Tomasi D, Volkow ND, Goldstein RZ.

Arch Gen Psychiatry. 2011 Mar;68(3):283-94. doi: 10.1001/archgenpsychiatry.2011.10.

30.

Regional sensitivity to neuroinflammation: in vivo and in vitro studies.

Liraz-Zaltsman S, Alexandrovich AG, Trembovler V, Fishbein I, Yaka R, Shohami E, Biegon A.

Synapse. 2011 Jul;65(7):634-42. doi: 10.1002/syn.20889. Epub 2011 Feb 25.

31.

Unique distribution of aromatase in the human brain: in vivo studies with PET and [N-methyl-11C]vorozole.

Biegon A, Kim SW, Alexoff DL, Jayne M, Carter P, Hubbard B, King P, Logan J, Muench L, Pareto D, Schlyer D, Shea C, Telang F, Wang GJ, Xu Y, Fowler JS.

Synapse. 2010 Nov;64(11):801-7. doi: 10.1002/syn.20791.

32.

Effect of cytomegalovirus infection on temporal lobe development in utero: quantitative MRI studies.

Hoffmann C, Grossman R, Bokov I, Lipitz S, Biegon A.

Eur Neuropsychopharmacol. 2010 Dec;20(12):848-54. doi: 10.1016/j.euroneuro.2010.08.006. Epub 2010 Sep 15.

PMID:
20833515
33.

Transient focal ischemia results in persistent and widespread neuroinflammation and loss of glutamate NMDA receptors.

Dhawan J, Benveniste H, Nawrocky M, Smith SD, Biegon A.

Neuroimage. 2010 Jun;51(2):599-605. doi: 10.1016/j.neuroimage.2010.02.073. Epub 2010 Mar 4.

34.

Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons.

Biegon A, Kim SW, Logan J, Hooker JM, Muench L, Fowler JS.

Biol Psychiatry. 2010 Apr 15;67(8):774-7. doi: 10.1016/j.biopsych.2010.01.004. Epub 2010 Feb 25.

35.

Intracranial electrode implantation produces regional neuroinflammation and memory deficits in rats.

Hirshler YK, Polat U, Biegon A.

Exp Neurol. 2010 Mar;222(1):42-50. doi: 10.1016/j.expneurol.2009.12.006. Epub 2009 Dec 21.

36.

D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window.

Adeleye A, Shohami E, Nachman D, Alexandrovich A, Trembovler V, Yaka R, Shoshan Y, Dhawan J, Biegon A.

Eur J Pharmacol. 2010 Mar 10;629(1-3):25-30. doi: 10.1016/j.ejphar.2009.11.066. Epub 2009 Dec 1.

37.

Critical role of the embryonic mid-hindbrain organizer in the behavioral response to amphetamine and methylphenidate.

Tilleman H, Kofman O, Nashelsky L, Livneh U, Roz N, Sillaber I, Biegon A, Rehavi M, Brodski C.

Neuroscience. 2009 Nov 10;163(4):1012-23. doi: 10.1016/j.neuroscience.2009.07.040. Epub 2009 Jul 24.

38.

Neural mechanisms of anger regulation as a function of genetic risk for violence.

Alia-Klein N, Goldstein RZ, Tomasi D, Woicik PA, Moeller SJ, Williams B, Craig IW, Telang F, Biegon A, Wang GJ, Fowler JS, Volkow ND.

Emotion. 2009 Jun;9(3):385-96. doi: 10.1037/a0015904. Erratum in: Emotion. 2009 Aug;9(4):487.

39.

Reinvestigation of the synthesis and evaluation of [N-methyl-(11)C]vorozole, a radiotracer targeting cytochrome P450 aromatase.

Kim SW, Biegon A, Katsamanis ZE, Ehrlich CW, Hooker JM, Shea C, Muench L, Xu Y, King P, Carter P, Alexoff DL, Fowler JS.

Nucl Med Biol. 2009 Apr;36(3):323-34. doi: 10.1016/j.nucmedbio.2008.12.013.

40.

Synthesis and PET studies of [(11)C-cyano]letrozole (Femara), an aromatase inhibitor drug.

Kil KE, Biegon A, Ding YS, Fischer A, Ferrieri RA, Kim SW, Pareto D, Schueller MJ, Fowler JS.

Nucl Med Biol. 2009 Feb;36(2):215-23. doi: 10.1016/j.nucmedbio.2008.11.010.

41.

Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation.

Wang GJ, Volkow ND, Telang F, Jayne M, Ma Y, Pradhan K, Zhu W, Wong CT, Thanos PK, Geliebter A, Biegon A, Fowler JS.

Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1249-54. doi: 10.1073/pnas.0807423106. Epub 2009 Jan 21.

42.

Inhibition of NR2B phosphorylation restores alterations in NMDA receptor expression and improves functional recovery following traumatic brain injury in mice.

Schumann J, Alexandrovich GA, Biegon A, Yaka R.

J Neurotrauma. 2008 Aug;25(8):945-57. doi: 10.1089/neu.2008.0521.

43.

Brain monoamine oxidase A activity predicts trait aggression.

Alia-Klein N, Goldstein RZ, Kriplani A, Logan J, Tomasi D, Williams B, Telang F, Shumay E, Biegon A, Craig IW, Henn F, Wang GJ, Volkow ND, Fowler JS.

J Neurosci. 2008 May 7;28(19):5099-104. doi: 10.1523/JNEUROSCI.0925-08.2008.

44.

Fat halo sign in the bowel wall of patients with Crohn's disease.

Amitai MM, Arazi-Kleinman T, Avidan B, Apter S, Konen E, Biegon A, Hertz M.

Clin Radiol. 2007 Oct;62(10):994-7. Epub 2007 Jul 20.

PMID:
17765465
45.
46.

D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury.

Yaka R, Biegon A, Grigoriadis N, Simeonidou C, Grigoriadis S, Alexandrovich AG, Matzner H, Schumann J, Trembovler V, Tsenter J, Shohami E.

FASEB J. 2007 Jul;21(9):2033-41. Epub 2007 Mar 9.

PMID:
17351125
47.

Metabolic and behavioral deficits following a routine surgical procedure in rats.

Frumberg DB, Fernando MS, Lee DE, Biegon A, Schiffer WK.

Brain Res. 2007 May 4;1144:209-18. Epub 2007 Feb 8.

48.

Quantitative MRI measurements of human fetal brain development in utero.

Grossman R, Hoffman C, Mardor Y, Biegon A.

Neuroimage. 2006 Nov 1;33(2):463-70. Epub 2006 Aug 30.

PMID:
16938471
49.

Serial microPET measures of the metabolic reaction to a microdialysis probe implant.

Schiffer WK, Mirrione MM, Biegon A, Alexoff DL, Patel V, Dewey SL.

J Neurosci Methods. 2006 Sep 15;155(2):272-84. Epub 2006 Mar 7.

PMID:
16519945
50.

Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.

Logan J, Ding YS, Lin KS, Pareto D, Fowler J, Biegon A.

Nucl Med Biol. 2005 Jul;32(5):531-42.

PMID:
15982584

Supplemental Content

Loading ...
Support Center